Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation
- PMID: 20211326
- DOI: 10.1016/j.amjcard.2009.10.064
Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation
Abstract
C-reactive protein (CRP) elevation is associated with an adverse cardiovascular prognosis after bare metal stent implantation. Data have suggested a similar association between preprocedural CRP and adverse events after drug-eluting stent (DES) implantation. The present study was designed to address whether such a relation exists after DES placement. After excluding patients presenting with an acute coronary syndrome with troponin I elevation, we analyzed the data from 936 consecutive patients who had undergone DES implantation from 2003 to 2007 and had a preprocedural CRP measurement. The patients were divided into 3 groups according to the preprocedural CRP level (<1.31, 1.31-3.76, and >3.76 mg/L). The primary end point was the composite of death and Q-wave myocardial infarction (QWMI) at 2 years of follow-up. Target vessel revascularization was also assessed. The rate of death/QWMI was not significantly different statistically among the CRP tertiles during the in-hospital period (0.6% vs 0.0% vs 0.6%, p = 0.5) or at 1 year of follow-up (1.9% vs 2.9% vs 4.5%, p = 0.2). At 2 years, death/QWMI had occurred in 2.9% of patients in the lowest, 5.2% in the middle, and 8.8% in the highest tertile (p = 0.006). The incidence of target vessel revascularization was similar in the 3 groups at 2 years of follow-up (13.2% vs 14.9% vs 16.9%, p = 0.5). On multivariate analysis, the upper tertile of CRP was an independent predictor of death/QWMI at 2 years (hazard ratio 2.5, 95% confidence interval 1.1 to 5.4, tertile 3 vs tertile 1, p = 0.006). In conclusion, high preprocedural CRP levels are associated with an increased risk of death and QWMI after DES implantation at long-term follow-up but not acutely. The CRP levels were not related to target vessel revascularization. Thus, an elevated CRP level in this population appears to be more of a marker of global cardiovascular risk than a predictor of post-DES-related complications.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005. Cardiovasc Revasc Med. 2009. PMID: 19595394
-
Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.Am J Cardiol. 2006 Sep 1;98(5):616-8. doi: 10.1016/j.amjcard.2006.03.039. Epub 2006 Jul 10. Am J Cardiol. 2006. PMID: 16923447
-
Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.Am J Cardiol. 2007 Dec 1;100(11):1619-24. doi: 10.1016/j.amjcard.2007.07.013. Epub 2007 Oct 10. Am J Cardiol. 2007. PMID: 18036358
-
Predictive value of C-reactive protein after drug-eluting stent implantation.Future Cardiol. 2010 Mar;6(2):167-79. doi: 10.2217/fca.09.159. Future Cardiol. 2010. PMID: 20230259 Review.
-
Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies.Heart. 2010 Mar;96(5):339-46. doi: 10.1136/hrt.2009.174912. Heart. 2010. PMID: 20197361 Review.
Cited by
-
Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.Inflamm Res. 2011 Oct;60(10):955-64. doi: 10.1007/s00011-011-0356-z. Epub 2011 Jul 10. Inflamm Res. 2011. PMID: 21744268
-
High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.PLoS One. 2014 Dec 4;9(12):e113352. doi: 10.1371/journal.pone.0113352. eCollection 2014. PLoS One. 2014. PMID: 25473831 Free PMC article.
-
Statin in the treatment of patients with myocardial infarction: A meta-analysis.Medicine (Baltimore). 2018 Mar;97(12):e0167. doi: 10.1097/MD.0000000000010167. Medicine (Baltimore). 2018. PMID: 29561426 Free PMC article. Clinical Trial.
-
Role of pre-procedural C-reactive protein level in the prediction of major adverse cardiac events in patients undergoing percutaneous coronary intervention: a meta-analysisof longitudinal studies.Inflammation. 2015 Feb;38(1):159-69. doi: 10.1007/s10753-014-0018-8. Inflammation. 2015. PMID: 25311976
-
Impact of pericoronary adipose tissue attenuation on clinical outcomes after percutaneous coronary intervention.EuroIntervention. 2025 Jun 2;21(11):e605-e616. doi: 10.4244/EIJ-D-24-00971. EuroIntervention. 2025. PMID: 40464675
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous